58 related articles for article (PubMed ID: 9085360)
1. Long-term inhibition of NO synthase induces cardiac hypertrophy with a decrease in adrenergic innervation.
Gerová M; Hartmannová B; Dolezel S; Jezek L
Physiol Res; 1996; 45(4):339-44. PubMed ID: 9085360
[TBL] [Abstract][Full Text] [Related]
2. Morphometric characteristics of cardiac hypertrophy induced by long-term inhibition of NO synthase.
Sládek T; Gerová M; Znojil V; Devát L
Physiol Res; 1996; 45(4):335-8. PubMed ID: 9085359
[TBL] [Abstract][Full Text] [Related]
3. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
Bernátová I; Pechánová O; Simko F
Physiol Res; 1996; 45(4):311-6. PubMed ID: 9085355
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.
Pacca SR; de Azevedo AP; De Oliveira CF; De Luca IM; De Nucci G; Antunes E
J Cardiovasc Pharmacol; 2002 Feb; 39(2):201-7. PubMed ID: 11791005
[TBL] [Abstract][Full Text] [Related]
5. L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension.
Simko F; Luptak I; Matuskova J; Krajcirovicova K; Sumbalova Z; Kucharska J; Gvozdjakova A; Simko J; Babal P; Pechanova O; Bernatova I
Eur J Clin Invest; 2005 Jun; 35(6):362-8. PubMed ID: 15948896
[TBL] [Abstract][Full Text] [Related]
6. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
Bernátová I; Pechánová O; Pelouch V; Simko F
J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
[TBL] [Abstract][Full Text] [Related]
7. Structural alterations in the heart after long-term L-NAME and D-NAME treatment.
Pechánová O; Bernátová I; Babál P
Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():6-9. PubMed ID: 10707823
[TBL] [Abstract][Full Text] [Related]
8. Long-term NO synthase inhibition affects heart weight and geometry of coronary and carotid arteries.
Kristek F; Gerová M
Physiol Res; 1996; 45(5):361-7. PubMed ID: 9085363
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular system of offsprings of hypertensive rats with defective nitric oxide production.
Gerová M; Bernátová I; Török J; Juráni M
Physiol Res; 2002; 51(5):465-74. PubMed ID: 12470199
[TBL] [Abstract][Full Text] [Related]
10. L-NAME-induced protein remodeling and fibrosis in the rat heart.
Pechánová O; Bernátová I; Pelouch V; Babál P
Physiol Res; 1999; 48(5):353-62. PubMed ID: 10625224
[TBL] [Abstract][Full Text] [Related]
11. Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats.
Liu Y; Tsuchihashi T; Kagiyama S; Matsumura K; Abe I; Fujishima M
J Hypertens; 1998 Aug; 16(8):1165-73. PubMed ID: 9794721
[TBL] [Abstract][Full Text] [Related]
12. Effect of long-term NO synthase inhibition on cyclic nucleotide content in rat tissues.
Pechánová O; Bernátová I
Physiol Res; 1996; 45(4):305-9. PubMed ID: 9085354
[TBL] [Abstract][Full Text] [Related]
13. Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat.
Khattab MM; Mostafa A; Al-Shabanah O
Kidney Blood Press Res; 2005; 28(4):243-50. PubMed ID: 16220007
[TBL] [Abstract][Full Text] [Related]
14. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
[TBL] [Abstract][Full Text] [Related]
16. Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension.
Bunbupha S; Prachaney P; Kukongviriyapan U; Kukongviriyapan V; Welbat JU; Pakdeechote P
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1189-97. PubMed ID: 26234646
[TBL] [Abstract][Full Text] [Related]
17. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor.
Paulis L; Zicha J; Kunes J; Hojna S; Behuliak M; Celec P; Kojsova S; Pechanova O; Simko F
Hypertens Res; 2008 Apr; 31(4):793-803. PubMed ID: 18633192
[TBL] [Abstract][Full Text] [Related]
18. Decreased cardiac baroreflex sensitivity is not due to cardiac hypertrophy in NG-nitro-L-arginine methyl ester-induced hypertension.
Lantelme P; Lo M; Sassard J
J Hypertens; 1994 Jul; 12(7):791-5. PubMed ID: 7963507
[TBL] [Abstract][Full Text] [Related]
19. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nitric oxide synthase by L-NAME improves ventricular performance in streptozotocin-diabetic rats.
Smith JM; Paulson DJ; Romano FD
J Mol Cell Cardiol; 1997 Sep; 29(9):2393-402. PubMed ID: 9299363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
